Using the center for epidemiologic studies depression scale to screen for depression in systemic lupus erythematosus

Arthritis Care and Research

Volumn 63, Issue 6, 2011, Pages 884-890

  Julian, Laura J ^a   Gregorich, Steven E ^a   Tonner, Chris ^a   Yazdany, Jinoos ^a   Trupin, Laura ^a   Criswell, Lindsey A ^a   Yelin, Ed ^a   Katz, Patricia P ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BECK DEPRESSION INVENTORY; CENTER FOR EPIDEMIOLOGIC STUDIES DEPRESSION SCALE; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MOOD DISORDER; QUALITY OF LIFE; RATING SCALE; SCREENING; SENSITIVITY AND SPECIFICITY; STRUCTURED INTERVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; CROSS-SECTIONAL STUDIES; DEPRESSION; DEPRESSIVE DISORDER; DEPRESSIVE DISORDER, MAJOR; EPIDEMIOLOGIC STUDIES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MASS SCREENING; MIDDLE AGED; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 79958792934     PISSN: 21514658     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/acr.20447     Document Type: Article

References (31)

1. ACR Ad Hoc Committee on Neuropsychiatric Lupus Nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
2. Kozora E, Thompson LL, West SG, Kotzin BL. Analysis of cognitive and psychological deficits in systemic lupus erythematosus patients without overt central nervous system disease. Arthritis Rheum 1996;39:2035-45. (Pubitemid 27009072)
3. Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, Stallworth CL, et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002;58:1214-20. (Pubitemid 34411865)
4. Radloff L. The CES-D Scale: a self-report depression measure for research in the general population. Appl Psychol Meas 1977;1:385-401.
5. Hochberg MC, for the Diagnostic and Therapeutic Criteria Committee of the American College of Rheumatology. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus [letter]. Arthritis Rheum 1997;40:1725.
6. Yelin E, Trupin L, Katz P, Criswell L, Yazdany J, Gillis J, et al. Work dynamics among persons with systemic lupus erythematosus. Arthritis Rheum 2007;57:56-63.
7. Karlson EW, Daltroy LH, Rivest C, Ramsey-Goldman R, Wright EA, Partridge AJ, et al. Validation of a Systemic Lupus Activity Questionnaire (SLAQ) for population studies. Lupus 2003;12:280-6. (Pubitemid 36458658)
8. Yazdany J, Yelin EH, Panopalis P, Trupin L, Julian L, Katz PP. Validation of the systemic lupus erythematosus activity questionnaire in a large observational cohort. Arthritis Rheum 2008;59:136-43. (Pubitemid 351171889)
9. Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992;30:473-83.
10. McDowell I. Measuring health: a guide to rating scales and questionnaires. 3rd ed. New York: Oxford University Press; 2006.
11. Martens MP, Parker JC, Smarr KL, Hewett JE, Slaughter JR, Walker SE. Assessment of depression in rheumatoid arthritis: a modified version of the Center for Epidemiologic Studies Depression Scale. Arthritis Rheum 2003;49:549-55. (Pubitemid 36988310)
12. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59 Suppl 20:22-33. (Pubitemid 29001829)
13. Ribeiro LS, Proietti FA. Interrelations between fibromyalgia, thyroid autoantibodies, and depression. J Rheumatol 2004;31: 2036-40. (Pubitemid 39336732)
14. Mohr DC, Hart SL, Julian L, Tasch ES. Screening for depression among patients with multiple sclerosis: two questions may be enough. Mult Scler 2007;13:215-9. (Pubitemid 46592774)
15. Ware JE, Kosinski M. SF-36 physical and mental health summary scales: a manual for users of version 1. 2nd ed. Lincoln (RI): QualityMetric; 2001.
16. Youden WJ. Index for rating diagnostic tests. Cancer 1950;3: 32-5.
17. Kraemer HC. Evaluating medical tests: objective and quantitative guidelines. Newbury Park (CA): Sage Publications; 1992.
18. Coffin M, Sukhatme S. Receiver operating characteristic studies and measurement errors. Biometrics 1997;53:823-37. (Pubitemid 27391014)
19. Nery FG, Borba EF, Viana VS, Hatch JP, Soares JC, Bonfa E, et al. Prevalence of depressive and anxiety disorders in systemic lupus erythematosus and their association with antiribosomal P antibodies. Prog Neuropsychopharmacol Biol Psychiatry 2008;32:695-700. (Pubitemid 351312367)
20. Haringsma R, Engels GI, Beekman AT, Spinhoven P. The criterion validity of the Center for Epidemiological Studies Depression Scale (CES-D) in a sample of self-referred elders with depressive symptomatology. Int J Geriatr Psychiatry 2004;19:558-63. (Pubitemid 38878006)
21. Wells KB, Stewart A, Hays RD, Burnam MA, Rogers W, Daniels M, et al. The functioning and well-being of depressed patients: results from the Medical Outcomes Study. JAMA 1989;262:914-9. (Pubitemid 19208948)
22. Covic T, Pallant J, Conaghan P, Tennant A. A longitudinal evaluation of the Center for Epidemiologic Studies-Depression scale (CES-D) in a rheumatoid arthritis population using Rasch analysis. Health Qual Life Outcomes 2007;5:41.
23. Beeney JE, Arnett PA. Endorsement of self-report neurovegetative items of depression is associated with multiple sclerosis disease symptoms. J Int Neuropsychol Soc 2008;14:1057-62.
24. Thombs BD, Hudson M, Bassel M, Taillefer SS, Baron M, and the Canadian Scleroderma Research Group. Sociodemographic, disease, and symptom correlates of fatigue in systemic sclerosis: evidence from a sample of 659 Canadian Scleroderma Research Group Registry patients. Arthritis Rheum 2009;61:966-73.
25. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16: 606-13. (Pubitemid 32823891)
26. Milette K, Hudson M, Baron M, Thombs BD. Comparison of the PHQ-9 and CES-D depression scales in systemic sclerosis: internal consistency reliability, convergent validity and clinical correlates. Rheumatology (Oxford) 2010;49:789-96.
27. Mitchell AJ, Coyne JC. Do ultra-short screening instruments accurately detect depression in primary care? A pooled analysis and meta-analysis of 22 studies. Br J Gen Pract 2007;57: 144-51. (Pubitemid 46242540)
28. US Preventive Services Task Force. Screening for depression in adults: US preventive services task force recommendation statement. Ann Intern Med 2009;151:784-92.
29. Baker K, Pope J, Fortin P, Silverman E, Peschken C. Work disability in systemic lupus erythematosus is prevalent and associated with socio-demographic and disease related factors. Lupus 2009;18:1281-8.
30. Nery FG, Borba EF, Hatch JP, Soares JC, Bonfa E, Neto FL. Major depressive disorder and disease activity in systemic lupus erythematosus. Compr Psychiatry 2007;48:14-9. (Pubitemid 44826975)
31. Panopalis P, Yazdany J, Gillis JZ, Julian L, Trupin L, Hersh AO, et al. Health care costs and costs associated with changes in work productivity among persons with systemic lupus erythematosus. Arthritis Rheum 2008;59:1788-95.